KYPROLIS subst sèche 60 mg flac
7680656900010
CH-65690
L01XG02
07.16.1.
Reimbursement limitations:
KYPROLIS.KDd
KYPROLIS en association avec le daratumumab et la dexaméthasone (KDd)
Après garantie de prise en …
1 / 3
google
Details
- Product number
- 6569001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: carfilzomibum 60 mg, sulfobutylbetadexum natricum 3000 mg, acidum citricum, natrii hydroxidum ad pH, nitrogenium, pro vitro corresp. natrium 216 mg.
Articles (1)
Kyprolis 60 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
3000.0 MG | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | TRGAS |
|
PRC
|
216.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1131.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2017
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 65690
- Drug name
- Kyprolis, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- L01XG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/11/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KYPROLIS subst sèche 60 mg flac
- Description (DE)
- KYPROLIS Trockensub 60 mg Durchstf
- Market launch
- 23/11/2015
- Narcotic (BTM)
- No